Christopher Heery
Chief Tech/Sci/R&D Officer chez ARCELLX, INC.
Fortune : 621 638 $ au 31/03/2024
Profil
Christopher R.
Heery is currently the Chief Medical Officer at Arcellx, Inc. Prior to this, he was the Chief Medical Officer at Precision BioSciences, Inc. from 2019 to 2021.
He also held the position of Chief Medical Officer at Bavarian Nordic A and was the Head-Clinical Trials at the National Cancer Institute.
Heery received his undergraduate degree from Duke University and his doctorate from Brody School of Medicine in 2006.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARCELLX, INC.
0,02% | 26/03/2024 | 8 938 ( 0,02% ) | 621 638 $ | 31/03/2024 |
Postes actifs de Christopher Heery
| Sociétés | Poste | Début |
|---|---|---|
| ARCELLX, INC. | Chief Tech/Sci/R&D Officer | 01/04/2021 |
Anciens postes connus de Christopher Heery
| Sociétés | Poste | Fin |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 23/04/2021 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
| BAVARIAN NORDIC A/S | Chief Tech/Sci/R&D Officer | - |
Formation de Christopher Heery
| Duke University | Undergraduate Degree |
| Brody School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PRECISION BIOSCIENCES, INC. | Health Technology |
| BAVARIAN NORDIC A/S | Health Technology |
| ARCELLX, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
